Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

EJHaem

Showing results (581-590 of 930) with videos related to

Pageof 93
Sort By:
Ejhaem|January 27, 2025
Association of the nutritional risk index recorded prior to allogeneic hematopoietic cell transplantation with the clinical prognosis in childrenHitomi Yonesu, Satoru Hamada, Hideki Sakiyama, et al.
Ejhaem|January 27, 2025
Clinical, immunophenotypic, and genomic findings of acute myeloid leukemia with RAM immunophenotype: Comparison with other CD56-positive acute leukemiasHanan Hamdan, Yen-Chun Liu, Sa A Wang, et al.
Ejhaem|January 27, 2025
Myeloproliferative neoplasm harboring both monosomy 7 and an <i>ALK/ROS1</i> fusion gene: Proposal for a new disease entityHideki Yoshida, Shinya Osone, Madoka Konishi, et al.
Ejhaem|January 27, 2025
What is the origin of the normal ranges of blood cell counts? An evolutionary perspectiveManon Zala, Vincent Alcazer, Laetitia Largeaud, et al.
Ejhaem|January 27, 2025
Increased serum B-cell maturation antigen levels evaluated with an Elecsys-based serum B-cell maturation antigen assay have a negative prognostic value in patients with newly diagnosed multiple myelomaEvangelos Terpos, Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, et al.
Ejhaem|January 27, 2025
Characteristics of relapsed/refractory diffuse large B-cell lymphoma patients with durable responses to maveropepimut-S, pembrolizumab, and cyclophosphamide: Long-term follow-up from the SPiReL trialArjun Pandey, Kim Roos, Yidi Jiang, et al.
Ejhaem|January 27, 2025
Real-world characteristics and outcomes of patients with multiple myeloma receiving second-line treatment in EnglandSally Moore, Laura Cornic, Christina-Jane Crossman-Barnes, et al.
Ejhaem|March 20, 2025
Bortezomib, Rituximab and Dexamethasone Regimen (BDR) in Waldenström Macroglobulinaemia: A Retrospective Real-World AnalysisThomas Hueso, Grégory Lazarian, Paul Chauvet, et al.
Ejhaem|March 11, 2025
Lisocabtagene Maraleucel for Richter's Transformation-A Case SeriesCourtney J Smith, Anmol Goyal, Brian R Smith, et al.
Ejhaem|October 17, 2024
VEXAS without vacuoles: Linking genotype to phenotypeSara Zhukovsky, Anton Rets, Tawnie Braaten, et al.
Pageof 93

Showing results (581-590 of 930) with videos related to

Sort By:
Pageof 93
Ejhaem|January 27, 2025
Association of the nutritional risk index recorded prior to allogeneic hematopoietic cell transplantation with the clinical prognosis in childrenHitomi Yonesu, Satoru Hamada, Hideki Sakiyama, et al.
Ejhaem|January 27, 2025
Clinical, immunophenotypic, and genomic findings of acute myeloid leukemia with RAM immunophenotype: Comparison with other CD56-positive acute leukemiasHanan Hamdan, Yen-Chun Liu, Sa A Wang, et al.
Ejhaem|January 27, 2025
Myeloproliferative neoplasm harboring both monosomy 7 and an <i>ALK/ROS1</i> fusion gene: Proposal for a new disease entityHideki Yoshida, Shinya Osone, Madoka Konishi, et al.
Ejhaem|January 27, 2025
What is the origin of the normal ranges of blood cell counts? An evolutionary perspectiveManon Zala, Vincent Alcazer, Laetitia Largeaud, et al.
Ejhaem|January 27, 2025
Increased serum B-cell maturation antigen levels evaluated with an Elecsys-based serum B-cell maturation antigen assay have a negative prognostic value in patients with newly diagnosed multiple myelomaEvangelos Terpos, Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, et al.
Ejhaem|January 27, 2025
Characteristics of relapsed/refractory diffuse large B-cell lymphoma patients with durable responses to maveropepimut-S, pembrolizumab, and cyclophosphamide: Long-term follow-up from the SPiReL trialArjun Pandey, Kim Roos, Yidi Jiang, et al.
Ejhaem|January 27, 2025
Real-world characteristics and outcomes of patients with multiple myeloma receiving second-line treatment in EnglandSally Moore, Laura Cornic, Christina-Jane Crossman-Barnes, et al.
Ejhaem|March 20, 2025
Bortezomib, Rituximab and Dexamethasone Regimen (BDR) in Waldenström Macroglobulinaemia: A Retrospective Real-World AnalysisThomas Hueso, Grégory Lazarian, Paul Chauvet, et al.
Ejhaem|March 11, 2025
Lisocabtagene Maraleucel for Richter's Transformation-A Case SeriesCourtney J Smith, Anmol Goyal, Brian R Smith, et al.
Ejhaem|October 17, 2024
VEXAS without vacuoles: Linking genotype to phenotypeSara Zhukovsky, Anton Rets, Tawnie Braaten, et al.
Pageof 93